GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » 3-Year Revenue Growth Rate

Alliance Pharma (LSE:APH) 3-Year Revenue Growth Rate : 6.20% (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma 3-Year Revenue Growth Rate?

Alliance Pharma's Revenue per Share for the six months ended in Jun. 2023 was £0.15.

During the past 12 months, Alliance Pharma's average Revenue per Share Growth Rate was 4.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Alliance Pharma was 20.50% per year. The lowest was -83.00% per year. And the median was 5.00% per year.


Competitive Comparison of Alliance Pharma's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alliance Pharma's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's 3-Year Revenue Growth Rate falls into.



Alliance Pharma 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Alliance Pharma  (LSE:APH) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Alliance Pharma 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Alliance Pharma (LSE:APH) Business Description

Traded in Other Exchanges
Address
Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB
Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).

Alliance Pharma (LSE:APH) Headlines

From GuruFocus

Q2 2021 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2020 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2022 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2018 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2020 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024